Vanguard Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Sell |
|
|||||
|
2025
Q1 | $2.88M | Buy |
|
|||||
|
2024
Q4 | $10.1M | Sell |
|
|||||
|
2024
Q3 | $13.6M | Buy |
|
|||||
|
2024
Q2 | $13.5M | Buy |
|
|||||
|
2024
Q1 | $28.1M | Buy |
|
|||||
|
2023
Q4 | $14.5M | Buy |
|
|||||
|
2023
Q3 | $7.86M | Buy |
|
|||||
|
2023
Q2 | $18.8M | Buy |
|
|||||
|
2023
Q1 | $19.1M | Buy |
|
|||||
|
2022
Q4 | $26.1M | Buy |
|
|||||
|
2022
Q3 | $29.6M | Sell |
|
|||||
|
2022
Q2 | $21.9M | Buy |
|
|||||
|
2022
Q1 | $13.7M | Sell |
|
|||||
|
2021
Q4 | $22.4M | Sell |
|
|||||
|
2021
Q3 | $34.7M | Buy |
|
|||||
|
2021
Q2 | $43.2M | Buy |
|
|||||
|
2021
Q1 | $50.4M | Buy |
|
|||||
|
2020
Q4 | $81.7M | Buy |
|
|||||
|
2020
Q3 | $52.9M | Sell |
|
|||||
|
2020
Q2 | $67M | Buy |
|
|||||
|
2020
Q1 | $11M | Buy |
|
|||||
|
2019
Q4 | $10.7M | Sell |
|
|||||
|
2019
Q3 | $2.96M | Sell |
|
|||||
|
2019
Q2 | $7.71M | Buy |
|
|||||
|
2019
Q1 | $7.89M | Buy |
|
|||||
|
2018
Q4 | $1.09M | Sell |
|
|||||
|
2018
Q3 | $6.01M | Buy |
|
|||||
|
2018
Q2 | $7.99M | Buy |
|
|||||
|
2018
Q1 | $6.65M | Buy |
|
|||||
|
2017
Q4 | $2.98M | Buy |
|
|||||
|
2017
Q3 | $2.74M | Buy |
|
|||||
|
2017
Q2 | $1.05M | Buy |
|